Evidence map›Paper›PMID 41313582›Full record

SynthesisInternational journal of clinical pharmacy2026

Pharmacist input to depression screening and management in patients with diabetes: a systematic review.

Mai I Al-Hawamdeh, Fatma Al Raisi, Rana Moustafa Al-Aladawi, Rana Abu-Huwaij, Antonella Pia Tonna

Erratum issuedAbstract readSystematic Review
In one paragraph

Synthesis in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Mai I Al-HawamdehUniversity of Jordan, Amman, 11942, Jordan.ORCID http://orcid.org/0000-0003-2433-4083
Fatma Al RaisiPharmacy Program, Oman College of Health Sciences, Muscat, Oman.ORCID http://orcid.org/0000-0002-4410-4237
Rana Moustafa Al-AladawiHamad General Hospital, Hamad Medical Corporation, Doha, Qatar. Rahmed4@hamad.qa.ORCID http://orcid.org/0000-0003-2432-0730
Rana Abu-HuwaijDepartment of Pharmacy, Faculty of Pharmacy, Amman Arab University, Amman, 11953, Jordan.
Antonella Pia TonnaSchool of Pharmacy, Applied Sciences and Public Health, Garthdee Road, Aberdeen, Scotland, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDepression affects approximately 5% of the global adult population, and its clinical and economic burden is particularly pronounced among individuals with chronic conditions such as diabetes mellitus, where it is frequently underdiagnosed and inadequately managed. Pharmacists play an important role in managing chronic diseases, including depression, through screening and medication management.

aimThis systematic review aimed to critically appraise and synthesize evidence on pharmacist input in screening and managing depression among patients with diabetes, either as sole providers or as part of a multidisciplinary team, and assess their impact on clinical outcomes and quality of life.

methodA systematic literature search was conducted in March 2023 and updated in March 2025 across Medline, Cumulative Index to Nursing and Allied Health Literature (CINAHL), and International Pharmaceutical Abstracts (IPA) databases, and reported in accordance with the PRISMA 2020 guidelines. Studies, irrespective of their design and published in English, reporting any pharmacist input in screening and managing depression among patients with diabetes, were included. No date restrictions were applied. Data extraction was based on Donabedian's quality-of-care model, which categorizes findings into structure, process, and outcome. The results were presented in both narrative and tabular formats. Quality was assessed by two independent researchers via the Mixed Methods Appraisal Tool.

resultsAmong the 1,852 records screened, 10 studies met the inclusion criteria. The studies described pharmacist input in depression screening n = 4, medication therapy management n = 6, telehealth services n = 2, and shared medical appointments n = 1. The most reported setting was outpatient clinics, n = 5. All studies demonstrated the positive impact of pharmacists on depression screening, treatment initiation, and medication adherence., Some interventions failed to significantly improve clinical parameters such as HbA1c levels or depressive symptoms. Barriers included limited physicians' response to screening results and a lack of structured care models.

conclusionThe positive impact of pharmacist interventions on this patient cohort is evident despite the variability across settings and intervention designs, reflecting the adaptability of pharmacist services. Results also suggest the need for standardized models of care and consistent outcome reporting.

Indexed as

DepressionDiabetes MellitusMass ScreeningPharmacistsProfessional RoleHumansPatient Care TeamQuality of LifeDepressionDiabetes mellitusPharmaceutical carePharmacists

Identifiers

PMID41313582
PMCPMC12992472

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.